Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-nasal vs Intra-venous Ketamine for MDD
NCT02644629Phase 4Completed
- Sponsor
- Shalvata Mental Health Center
- Start
- Apr 2016
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by Shalvata Mental Health Center. Started Apr 2016; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02644629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644629.